Page last updated: 2024-12-07
af-cx 921xx
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 132754 |
SCHEMBL ID | 10914499 |
SCHEMBL ID | 10914493 |
MeSH ID | M0117644 |
Synonyms (24)
Synonym |
---|
77946-49-7 |
g4kr7ws6tp , |
unii-g4kr7ws6tp |
2-(aminophenylmethylene)benzo(b)thiophene-3-one |
af-cx 921 |
af-cx 921xx |
af-cx 921 xx |
af-cx-921-xx |
benzo(b)thiophen-3(2h)-one, 2-(aminophenylmethylene)-, (e)- |
(e)-2-[(amino)phenylmethylene]-benzo[b]-thiophen-3(2h)-one |
XIJTZTNNGQLXAT-UHFFFAOYSA-N |
2-[(amino)phenylmethylene]-benzo[b]-thiophen-3(2h)-one |
(e)-2-[(amino)phenylmethylene]-benzo[b]thiophen-3(2h)-one |
XIJTZTNNGQLXAT-FYWRMAATSA-N |
(e)-2-[(amino)-phenylmethylene]-benzo[b]thiophen-3(2h)-one |
SCHEMBL10914499 |
SCHEMBL10914493 |
2-(aminobenzylidene)-3(2h)-benzo[b]thiophenone |
af-cx-921 |
(2e)-2-(amino(phenyl)methylidene)-2,3-dihydro-1-benzothiophen-3-one |
benzo(b)thiophen-3(2h)-one, 2-(aminophenylmethylene)-, (2e)- |
(2e)-2-(amino(phenyl)methylidene)-1-benzothiophen-3-one |
2-(benzenecarboximidoyl)-1-benzothiophen-3-ol |
AKOS040745499 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (4)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |